Yahoo
OTC Markets OTCPK - Delayed Quote USD

UMAX Group Corp. (UMAX)

0.0001 0.0000 (0.00%)
At close: November 6 at 4:00:00 PM EST
Chart Range Bar
Loading chart for UMAX
  • Previous Close 0.0001
  • Open 0.0002
  • Bid 0.0001 x --
  • Ask 0.0002 x --
  • Day's Range 0.0002 - 0.0002
  • 52 Week Range 0.0001 - 0.0002
  • Volume 103,849
  • Avg. Volume 4,175
  • Market Cap (intraday) 7,047
  • Beta (5Y Monthly) 19.08
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

UMAX Group Corp., a development stage company, doing business as UMAX Nutrition, focuses on developing and distributing natural and organic nutrition, and dietary supplements to the nutritional industry. Its product line provides dietary needs for weight loss, colon health, sexual health, body building, and general health and vitality. The company's products include UPRITE XXL, a natural herbal male enhancement supplement providing an alternative to prescription erectile dysfunction medication; green coffee bean extract; and RASPBERRY KETONE, an anti-oxidant and fat burning ingredient. UMAX Group Corp. was founded in 2011 and is based in Los Angeles, California.

www.umaxcorp.com

--

Full Time Employees

April 30

Fiscal Year Ends

Entertainment

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

UMAX
0.00%
S&P 500 (^GSPC)
7.76%

1-Year Return

UMAX
50.00%
S&P 500 (^GSPC)
9.77%

3-Year Return

UMAX
94.74%
S&P 500 (^GSPC)
68.96%

5-Year Return

UMAX
99.89%
S&P 500 (^GSPC)
57.04%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -97.55%

  • Return on Equity (ttm)

    -233.54%

  • Revenue (ttm)

    13.5k

  • Net Income Avi to Common (ttm)

    -120.4k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    147.34k

  • Total Debt/Equity (mrq)

    43.23%

  • Levered Free Cash Flow (ttm)

    -69.56k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: